175 related articles for article (PubMed ID: 36565610)
1. Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome.
Klimova EM; Bozhkov AI; Lavinska OV; Drozdova LA; Kurhuzova NI
Immunobiology; 2023 Jan; 228(1):152316. PubMed ID: 36565610
[TBL] [Abstract][Full Text] [Related]
2. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of immunological biomarkers in COVID-19 and bacterial pneumonia.
Abakar MAA; Hamad DHA; Faisal E; Omer HMF; Faki MTM; Idris AEM; Omer R; Osman Z; Elhassan EAG; Abrahim-Holie MA; Hakami MA; Alghamdi A; Alfahed A; Aloraini GS; Alharthi NS; Waggiallah HA
J Med Life; 2023 Dec; 16(12):1844-1851. PubMed ID: 38585537
[TBL] [Abstract][Full Text] [Related]
4. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
Acosta-Ampudia Y; Monsalve DM; Rojas M; Rodríguez Y; Zapata E; Ramírez-Santana C; Anaya JM
J Infect Dis; 2022 Jun; 225(12):2155-2162. PubMed ID: 35079804
[TBL] [Abstract][Full Text] [Related]
5. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study.
Maamar M; Artime A; Pariente E; Fierro P; Ruiz Y; Gutiérrez S; Tobalina M; Díaz-Salazar S; Ramos C; Olmos JM; Hernández JL
Curr Med Res Opin; 2022 Jun; 38(6):901-909. PubMed ID: 35166141
[TBL] [Abstract][Full Text] [Related]
6. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics.
Bizjak DA; Stangl M; Börner N; Bösch F; Durner J; Drunin G; Buhl JL; Abendroth D
Front Immunol; 2022; 13():1004545. PubMed ID: 36211365
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
Smail SW; Babaei E; Amin K; Abdulahad WH
Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19.
Melero I; Villalba-Esparza M; Recalde-Zamacona B; Jiménez-Sánchez D; Teijeira Á; Argueta A; García-Tobar L; Álvarez-Gigli L; Sainz C; Garcia-Ros D; Toledo E; Abengozar-Muela M; Fernández-Alonso M; Rodríguez-Mateos M; Reina G; Carmona-Torre F; Quiroga JA; Del Pozo JL; Cross A; López-Janeiro Á; Hardisson D; Echeveste JI; Lozano MD; Ho LP; Klenerman P; Issa F; Landecho MF; de Andrea CE
Chest; 2022 Nov; 162(5):1006-1016. PubMed ID: 35714708
[TBL] [Abstract][Full Text] [Related]
10. [Influence of erythropoietin on immunological system of patients with chronic renal failure].
Debska-Slizień A; Rutkowski B; Manitius J; Zdrojewski Z; Szołkiewicz M; Bułło B; Lizakowski S; Myśliwska J; Myśliwski A; Bryl E; Trzonkowski P; Bakowska A; Rachoń D
Pol Merkur Lekarski; 2003 Oct; 15(88):326-7; discussion 327-9. PubMed ID: 14974359
[TBL] [Abstract][Full Text] [Related]
11. The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19.
Schultheiß C; Willscher E; Paschold L; Gottschick C; Klee B; Henkes SS; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Höll JI; Gekle M; Mikolajczyk R; Binder M
Cell Rep Med; 2022 Jun; 3(6):100663. PubMed ID: 35732153
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the inflammatory response to COVID-19 illness in pregnancy.
Forrest AD; Poliektov NE; Easley KA; Michopoulos V; Ravi M; Cheedarla N; Neish AS; Cheedarla S; Roback JD; Dunlop AL; Badell ML; Dude CM
Cytokine; 2023 Oct; 170():156319. PubMed ID: 37544133
[TBL] [Abstract][Full Text] [Related]
13. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery.
Ruenjaiman V; Sodsai P; Kueanjinda P; Bunrasmee W; Klinchanhom S; Reantragoon R; Tunvirachaisakul C; Manothummetha K; Mejun N; Liengswangwong K; Torvorapanit P; Paitoonpong L; Putcharoen O; Palaga T; Hirankarn N;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):993-1004. PubMed ID: 36220753
[TBL] [Abstract][Full Text] [Related]
14. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Mangoni AA
Front Immunol; 2021; 12():696085. PubMed ID: 34163491
[TBL] [Abstract][Full Text] [Related]
15. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID.
Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ
J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444
[TBL] [Abstract][Full Text] [Related]
16. Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.
Bergantini L; d'Alessandro M; Gangi S; Bianchi F; Cameli P; Perea B; Meocci M; Fabbri G; Marrucci S; Ederbali M; Bargagli E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629176
[TBL] [Abstract][Full Text] [Related]
17. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms.
Son K; Jamil R; Chowdhury A; Mukherjee M; Venegas C; Miyasaki K; Zhang K; Patel Z; Salter B; Yuen ACY; Lau KS; Cowbrough B; Radford K; Huang C; Kjarsgaard M; Dvorkin-Gheva A; Smith J; Li QZ; Waserman S; Ryerson CJ; Nair P; Ho T; Balakrishnan N; Nazy I; Bowdish DME; Svenningsen S; Carlsten C; Mukherjee M
Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 36137590
[TBL] [Abstract][Full Text] [Related]
18. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome.
Queiroz MAF; Neves PFMD; Lima SS; Lopes JDC; Torres MKDS; Vallinoto IMVC; Bichara CDA; Dos Santos EF; de Brito MTFM; da Silva ALS; Leite MM; da Costa FP; Viana MNDSA; Rodrigues FBB; de Sarges KML; Cantanhede MHD; da Silva R; Bichara CNC; van den Berg AVS; Veríssimo AOL; Carvalho MDS; Henriques DF; Dos Santos CP; Nunes JAL; Costa IB; Viana GMR; Carneiro FRO; Palacios VRDCM; Quaresma JAS; Brasil-Costa I; Dos Santos EJM; Falcão LFM; Vallinoto ACR
Front Cell Infect Microbiol; 2022; 12():922422. PubMed ID: 35846757
[TBL] [Abstract][Full Text] [Related]
20. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
